Skip to main content
. Author manuscript; available in PMC: 2010 Apr 1.
Published in final edited form as: Stroke. 2009 Feb 10;40(4):1140–1147. doi: 10.1161/STROKEAHA.108.541847

Table 6.

30-day Stroke and Death Rates from CEA Arm of Major CEA Clinical Trials by Sex and Symptomatic Status

Women Men
Symptomatic
  European Carotid Surgery Trial (ECST) 9 11.1% (49/440) 6.4% ( 70/1095)
  North American Symptomatic Carotid Endarterectomy Trial (NASCET) + Aspirin and Carotid Endarterectomy Trial (ACE) 14 7.6% (57/753) 5.9% (107/1810)
Asymptomatic
  Asymptomatic Carotid Atherosclerosis Study (ACAS) 3,4 3.6% (10/281) 1.7% ( 9/544)
  Asymptomatic Carotid Surgery Trial (ACST) 5 3.6% (17/469) 2.5% (23/936)